Buy Insulent Corp. (PODD) on Weakness - Canaccord Genuity

August 9, 2012 9:15 AM EDT Send to a Friend
Get Alerts PODD Hot Sheet
Price: $40.85 -0.58%

Rating Summary:
    13 Buy, 4 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 21 | New: 16
Trade PODD Now!
Join SI Premium – FREE
Today Canaccord Genuity reiterated their Buy rating on Insulet Corporation (NASDAQ: PODD) but cut the price target to $24.50 (from $27.00).

"Strength in the core OmniPod business was very encouraging, but offset by weaker-than-expected results from NDI," said William J. Plovanic.

"Given the continued back-and-forth with the FDA, we are now modeling for Gen2 to gain FDA clearance by YE/12, pushing out an acceleration in growth and margin improvement into the Q2/13," he added.

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $18.72 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment